erythromycin has been researched along with quetiapine fumarate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, ZN; Li, HD; Li, KY; Li, X; Peng, WX; Zhang, BK | 1 |
| Cheng, ZN; Li, HD; Li, KY; Li, X | 1 |
1 trial(s) available for erythromycin and quetiapine fumarate
| Article | Year |
|---|---|
Metabolic mechanism of quetiapine in vivo with clinical therapeutic dose.
Topics: Adolescent; Adult; Antipsychotic Agents; Area Under Curve; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dibenzothiazepines; Enzyme Inhibitors; Erythromycin; Female; Humans; Male; Midazolam; Middle Aged; Quetiapine Fumarate; Schizophrenia | 2005 |
1 other study(ies) available for erythromycin and quetiapine fumarate
| Article | Year |
|---|---|
Effect of erythromycin on metabolism of quetiapine in Chinese suffering from schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Area Under Curve; Asian People; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dibenzothiazepines; Erythromycin; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Quetiapine Fumarate; Schizophrenia | 2005 |